Table III.
Adverse effects and tumor markers.
| Effect on serum level of tumor marker | |||
|---|---|---|---|
|
|
|||
| Case | Adverse effect | 1 month post treatment | 6 months post treatment |
| 1 | Mild liver dysfunction | Elevated | Decreased |
| 2 | None | Decreased | - |
| 3 | None | Elevated | Elevated |
| 4 | None | Decreased | Elevated |
| 5 | None | Elevated | - |
| 6 | None | Decreased | Decreased |
| 7 | None | Elevated | - |
| 8 | Mild liver dysfunction | Decreased | Elevated |
| 9 | Mild liver dysfunction | Decreased | Decreased |
| 10 | None | Decreased | - |
| 11 | None | Decreased | Decreased |
| 12 | Mild liver and renal dysfunction | Decreased | Elevated |
-, not evaluable.